TICKER
NAME
HIGHLIGHTS
WEBCASTS
EARNINGS
CONFERENCES
SPLITS
IPOs
ECONOMIC EVENTS
DIVIDENDS
Oxygen Biotherapeutics, Inc.
INVESTOR EVENTS
SNAPSHOT
PRESS RELEASES
FINANCIAL REPORTS
REQUEST INFO
RECENT FINANCIAL NEWS
Back to Directory
Recent News
TITLE
DATE
Oxygen Biotherapeutics Announces Registered Financing for up to $7.5 Million in Gross Proceeds
9-Dec-2011
Oxygen Biotherapeutics to Present at 23rd Annual Piper Jaffray Healthcare Conference
22-Nov-2011
Oxygen Biotherapeutics to Voluntarily Withdraw Secondary Listing From SIX Swiss Stock Exchange
27-Oct-2011
Oxygen Biotherapeutics Names Dr. Ronald Blanck Chairman of the Board
30-Sep-2011
Oxygen Biotherapeutics Reports First Quarter FY2012 Financial Results and Announces Conference Call and Webcast for Shareholders
19-Sep-2011
Oxygen Biotherapeutics Announces Dismissal of Chris J. Stern as CEO and Appointments of Michael B. Jebsen as Interim CEO and Rene Eckert as Interim Chairman
24-Aug-2011
Photo Release -- Beat the Summertime Skin Blues With Dermacyte(R) Summer Rescue Bundle to Soothe Dry Skin and Bring Back a Youthful Glow
1-Aug-2011
Oxygen Biotherapeutics and Aurum Biosciences Sign Letter of Intent to Explore the Use of Oxycyte(R) PFC for Imaging and Therapeutic Intervention of Acute Ischemic Stroke
25-Jul-2011
Global Interest in the Potential Medical Benefits of Novel Perfluorocarbon At All Time High
20-Jul-2011
Oxygen Biotherapeutics Reports Financial Results for Fiscal Year 2011
14-Jul-2011
Oxygen Biotherapeutics Announces Closing of Its Previously Announced Private Placement of Unregistered Convertible Notes and Warrants
1-Jul-2011
Oxygen Biotherapeutics Announces $4.6 Million Private Placement of Unregistered Convertible Note and Warrants
22-Jun-2011
Oxygen Biotherapeutics Announces FY2011 Year-End and Fourth Quarter Financial Results Conference Call and Webcast
17-Jun-2011
Oxygen Biotherapeutics Receives Approval to Expand Phase IIb Trials With Oxycyte(R) PFC for Traumatic Brain Injury Into India
7-Jun-2011
Oxygen Biotherapeutics' Chairman and CEO Chris Stern Announces Retirement of President and COO Richard Kiral
31-Mar-2011
Oxygen Biotherapeutics Reports Financial Results for Third Quarter FY2011
21-Mar-2011
Oxygen Biotherapeutics Announces Third Quarter FY2011 Financial Results Conference Call and Webcast
14-Mar-2011
Oxygen Biotherapeutics Signs Agreement to Sell DERMACYTE Products to Mexican Sales and Distribution Company
10-Mar-2011
Oxygen Biotherapeutics Receives U.S. Army Grant for Studies of Oxycyte(R), a Novel Traumatic Brain Injury Therapeutic for Combat Casualties
2-Mar-2011
Oxygen Biotherapeutics and Hackensack University Medical Center Sign Research Contract Funded by the U.S. Department of Defense to Study Wound Healing Properties of Wundecyte(TM) Gel
28-Jan-2011
Oxygen Biotherapeutics Signs Agreement to Sell DERMACYTE Products to Swiss Sales and Distribution Company
12-Jan-2011
Oxygen Biotherapeutics and Sarasota Medical Products Sign Binding Letter of Intent to Pursue Joint Research and Development in Chronic Ischemic Wound Care
16-Dec-2010
Oxygen Biotherapeutics, Inc.
